Back

dr. S. (Sander) van Doorn

Assistant Professor
dr. S. (Sander) van Doorn
  • Department of General Practice
  • Julius Center Research Program Cardiovascular Epidemiology

Research Output (16)

The Number of Concomitant Drugs and the Safety of Direct Oral Anticoagulants in Routine Care Patients with Atrial Fibrillation

van den Dries Carline J, van Doorn Sander, Souverein Patrick, Pajouheshnia Romin, Moons Karel G M, Hoes Arno W, Geersing Geert-Jan, van den Ham Hendrika A 23 dec 2020, In: TH open : companion journal to thrombosis and haemostasis. 4 , p. e417-e426

Clinical utility of limited channel sleep studies versus polysomnography for obstructive sleep apnoea

van Doorn Sander, Heus Pauline, Damen Johanna A.A.G., Spijker Rene, Japenga Eva J., Reesink Herre, Scholten Rob J.P.M., Hooft Lotty 15 dec 2020, In: Cochrane Database of Systematic Reviews. 2020

Strategies to reduce the use of low-value medical tests in primary care: a systematic review

Takada Toshihiko, Heus Pauline, van Doorn Sander, Naaktgeboren Christiana A., Weenink Jan-Willem, van Dulmen Simone A., Hooft Lotty 1 dec 2020, In: British Journal of General Practice. 70 , p. E858-E865

Diagnosing deep vein thrombosis in cancer patients with suspected symptoms:an individual participant data meta-analysis

Takada Toshihiko, van Doorn Sander, Parpia Sameer, de Wit Kerstin, Anderson David R, Stevens Scott M, Woller Scott C, Ten Cate-Hoek Arina J, Elf Johan L, Kraaijenhagen Roderik A, Schutgens Roger E G, Wells Phil S, Kearon Clive, Moons Karel G M, Geersing Geert-Jan 20 mei 2020, In: Journal of thrombosis and haemostasis : JTH. 18 , p. 2245-2252 8 p.

Integrated management of atrial fibrillation in primary care:results of the ALL-IN cluster randomized trial

van den Dries Carline J, van Doorn Sander, Rutten Frans H, Oudega Ruud, van de Leur Sjef J C M, Elvan Arif, Oude Grave Lisa, Bilo Henk J G, Moons Karel G M, Hoes Arno W, Geersing Geert-Jan 29 feb 2020, In: European heart journal. 41 , p. 2836-2844 9 p.

Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation:rationale and design of the FRAIL-AF randomised controlled trial

Joosten Linda P T, van Doorn Sander, Hoes Arno W, Nierman Melchior C, Wiersma Nynke M, Koek Huiberdina L, Hemels Martin E W, Huisman Menno V, Roes Kit C, van den Bor Rutger M, Buding Wim F, Rutten Frans H, Geersing Geert-Jan 29 dec 2019, In: BMJ Open. 9

Stroke Rate Variation and Anticoagulation Benefit in Atrial Fibrillation

Joosten Linda P.T., Van Doorn Sander, Rutten Frans H., Geersing Geert Jan 4 jun 2019, In: Annals of Internal Medicine. 170 , p. 816-817 2 p.

Op weg naar ‘de beste DOAC’?

van Doorn Sander, Rutten Frans H., Geersing Geert Jan 21 mrt 2019, In: Nederlands Tijdschrift voor Geneeskunde. 163

Risk of cardiac and non-cardiac adverse events in community-dwelling older patients with atrial fibrillation:A prospective cohort study in the Netherlands

Van Doorn Sander, Tavenier Annerien, Rutten Frans H., Hoes Arno W., Moons Karel G.M., Geersing Geert Jan 1 aug 2018, In: BMJ Open. 8

Opportunistic screening for heart failure with natriuretic peptides in patients with atrial fibrillation:A meta-analysis of individual participant data of four screening studies

Van Doorn Sander, Geersing Geert Jan, Kievit Rogier F., Van Mourik Yvonne, Bertens Loes C., Van Riet Evelien E.S., Boonman-De Winter Leandra J., Moons Karel G.M., Hoes Arno W., Rutten Frans H. 23 mrt 2018, In: Heart. 104 , p. 1236-1237

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.